News
AstraZeneca has proposed price cuts to its drugs in the United States, its CEO said on Tuesday, days after unveiling a $50 ...
Pascal Soriot's comments came during AstraZeneca's Q2 earnings call in regard to President Donald Trump’s newly announced ...
AstraZeneca share price held steady this week after the company published strong financial results on Tuesday.
AstraZeneca’s chief executive has said the drugmaker is a “very American company” amid growing speculation it will shift its ...
AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was “rapidly ...
The pharmaceutical giant said second-quarter revenue increased to $14.46 billion from $12.94 billion. Revenue in its oncology ...
AstraZeneca adjusts its U.S. strategy by proposing drug price cuts and expanding local production in response to pressure ...
AstraZeneca has dropped the lead candidate from its $200 million buyout of Neogene Therapeutics as part of a wider cell ...
AstraZeneca shares are rising in premarket trading Tuesday after the pharma giant beat second-quarter estimates on strong U.S ...
AstraZeneca (NASDAQ:AZN) has announced an interim dividend of $1.03/share. The record date for the first interim dividend for 2025, payable on September 8, 2024, will be August ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback